Andere Sprachen Hubei Guangji Pharmaceutical Co., Ltd.

Aktien

000952

CNE0000010R5

000952

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 07.06.2024			% 5 Tage	% 1. Jan.
5.26 ^CNY	+4.57%		-9.00%	-34.17%

25.04.	Hubei Guangji Pharmaceutical Co., Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
25.04.	Hubei Guangji Pharmaceutical Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25.04.
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25.04.
Guangji Pharmaceutical Gets Nod to Produce Entecavir	07.11.
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	20.10.23
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30.08.23
Guangji Pharma to Establish Joint Innovation Laboratory With Jiangnan University	15.06.23
Guangji Pharma to Borrow 281 Million Yuan From Bank to Support Acquisition Deals	17.05.23
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27.04.23
Hubei Guangji Pharmaceutical Announces Profit Distribution Proposal for 2022	20.04.23
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	19.04.23
Guangji Pharma Registers Diabetes-Related Infection Drug	29.03.23
Hubei Guangji Pharma to Invest 468 Million Yuan in Parkson Biotechnology Amid Bankruptcy Reorganization	08.02.23
Hubei Guangji Pharma Signs 6MW Solar Power Project	15.12.22
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27.10.22
Guangji Pharmaceutical Unit to Resume Production After Three-Month Stoppage	04.10.22
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	18.08.22
Hubei Guangji Pharmaceutical Jikang Medicine Co., Ltd. announced that it has received CNY 45 million in funding from Hubei Guangji Pharmaceutical Co., Ltd.	19.07.22
Hubei Guangji Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2021, Payable on May 27, 2022	19.05.22
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28.04.22
Hubei Guangji Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021	21.04.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Hubei Guangji Pharmaceutical Co., Ltd.

Aktien

000952

CNE0000010R5

000952

Andere Sprachen

Filter